---
document_datetime: 2023-09-21 17:42:16
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/monotard-epar-all-authorised-presentations_en.pdf
document_name: monotard-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9379986
conversion_datetime: 2025-12-26 19:28:39.323219
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical form      | Route of administration   | Packaging    | Content (concentration)   | Package size   |
|-----------------|-----------------|------------|--------------------------|---------------------------|--------------|---------------------------|----------------|
| EU/1/02/235/001 | Monotard        | 40 IU/ml   | Suspension for injection | Subcutaneous use          | Vial (glass) | 10ml (1.4 mg/ml)          | 1 vial         |
| EU/1/02/235/002 | Monotard        | 40 IU/ml   | Suspension for injection | Subcutaneous use          | Vial (glass) | 10 ml (1.4 mg/ml)         | 5 vials        |
| EU/1/02/235/003 | Monotard        | 100 IU/ml  | Suspension for injection | Subcutaneous use          | Vial (glass) | 10ml (3.5 mg/ml)          | 1 vial         |
| EU/1/02/235/004 | Monotard        | 100 IU/ml  | Suspension for injection | Subcutaneous use          | Vial (glass) | 10 ml (3.5 mg/ml)         | 5 vials        |

## Medicinal Product no longer authorised Invented name Strength Pharmaceutical form Route of administration Monotard 40 IU/ml Suspension for injection Subcutaneous use Monotard 40 IU/ml Suspension for injection Subcutaneous use Monotard 100 IU/ml Suspension for injection Subcutaneous use Monotard 100 IU/ml Suspension for injection Subcutaneous use